Venkys (India) Ltd

- No major new debt or equity fundraising planned in the next 2-3 years. - Existing term loans for animal health product division and SPF project have been fully paid off. - Current borrowings (~INR 170 crores) primarily consist of working capital limits, which are expected to remain stable and not reduce significantly. - Capital expenditures are minimal, mostly normal capitalization (~INR 40-50 crores) for existing poultry units, funded through internal accruals. - New animal health care project (cost ~INR 67 crores) capitalization is already completed using internal accruals, no external borrowing. - Overall, ample capacity utilization and no immediate plans for raising funds through debt or equity.

- No major capex projects planned in the next 2-3 years; ample existing capacity across segments (poultry, feed mill, AHP, oilseed) to cater to demand. - New animal health care plant project (~INR 67 crores) is near completion with production expected to start in the last quarter of FY24 (December 2023). - This new plant will ensure regulatory compliance and add 15-18% additional volume in the animal health segment next financial year. - Capitalization for the new AHP project is complete and funded through internal accruals; only regulatory clearance pending. - Normal annual capitalization of INR 40-50 crores expected for maintenance/upkeep of existing poultry units, funded internally. - No significant external debt planned; current borrowings mainly working capital which will remain stable.

- Venky's expects continuous growth of approximately 10% in revenues, particularly from QSR (Quick Service Restaurant) sector expansion in India. - QSRs are growing steadily post-COVID, with an emphasis on chicken menu items, driving demand. - Venky’s serves QSRs pan-India for frozen chicken products; chilled chicken supplies are regional. - New animal health plant coming online by year-end will add 15-20% volume growth in that segment. - Overall poultry segment volume expected to be strong with traditional consumption upticks in Q3 and Q4. - Oilseed segment volume likely to maintain previous year’s levels but no significant growth due to edible oil price pressures. - Feed capacity utilization currently moderate, indicating potential for increased production without large capex. - Venky's plans to introduce new fast-food products in its outlets to drive expansion and growth.

- Venky's expects continuous growth of approximately 10% annually from QSR (Quick Service Restaurants) sector sales, driven by expanding QSR business activities and menu items, particularly in chicken products. - The poultry segment is anticipated to see strong volume growth going ahead, with profitability expected to improve in Q3 and Q4 due to traditional consumption patterns. - Animal Health Products (AHP) segment will benefit from a new plant starting production by end of FY'24, expected to boost top-line revenue by around 15-20%. - Margins in oilseed and edible oil segments may remain under pressure till after elections (May), but the company aims to sustain volume at last year's level. - Feed price stability and improved production efficiency (feed conversion ratio improved from 1.7 to 1.5) support margin improvement. - Overall, growth in revenue, operating earnings, and profits is expected to be supported by increasing QSR demand, expanded capacity, and introduction of new products.

- The transcript does not explicitly mention specific details about the current or expected orderbook or pending orders for Venky's. - However, the management indicated that they have sufficient volumes planned and packed production for the remaining part of the current and next quarter, implying a healthy order pipeline. - For the poultry segment, volumes are expected to be strong going forward. - In the QSR segment, Venky's is actively supplying frozen chicken pan-India, indicating ongoing and potential orders across regions. - New product introductions in the fast food chain segment (Venky's Express and franchises) are expected soon, signaling anticipated growth in orders. - The new animal health product plant coming online is expected to boost revenue by around 15%-18%, reflecting expected incremental orders. - Overall, capacity utilization suggests ample capacity to cater to future demand without immediate constraints.